<DOC>
	<DOCNO>NCT01093976</DOCNO>
	<brief_summary>The goal propose study evaluate efficacy safety dronabinol individual obsessive-compulsive disorder ( OCD ) obsessive-compulsive spectrum disorder , trichotillomania ( TTM ) pathological skin picking ( PSP ) . Fifteen patient OCD , TTM , PSP receive 12 week open-label treatment dronabinol . The hypothesis test dronabinol effective well tolerated patient disorder . The propose study provide need data treatment disable disorder currently lack clearly effective treatment .</brief_summary>
	<brief_title>Marinol Trichotillomania Obsessive Compulsive Disorder</brief_title>
	<detailed_description>The study consist twelve week open-label dronabinol . All eligible study subject start open-label dronabinol 2.5mg/day 3 week . The dose increase 5mg/day visit 2 ( Week 3 ) , to10mg/day visit 3 ( Week 6 ) , 15mg/day Visit 4 ( Week 9 ) unless clinical improvement attain low dose ( clinical improvement assess investigator respect obsessive thought , urge compulsive behavior ) . Subjects see every three week 12-week , open-label study . All efficacy safety assessment perform visit . Subjects compliant use study medication ( i.e . fail take medication three consecutive day ) discontinue study . Laboratory test , include liver function test , blood chemistry panel , urine toxicology complete subject baseline opinion study physician medical history subject warrant test safety . All female , regardless age , undergo urine pregnancy test screen subject require urine drug screen screen visit test drug abuse . At study conclusion , subject give option continue medication ( via prescription ) cover insurance , follow clinic refer another psychiatrist . All study subject offer follow-up care CBT and/or medication outpatient clinic ( covered insurance ) give list appropriate referral community .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Trichotillomania</mesh_term>
	<mesh_term>Dronabinol</mesh_term>
	<criteria>1 . Age 1865 year 2 . Obsessivecompulsive disorder ( OCD ) , Trichotillomania ( TTM ) , Pathological Skin Picking ( PSP ) primary psychiatric diagnosis 3 . ( If OCD ) Subject report ≥two fail treatment use selective serotonin reuptake inhibitor ( SSRIs ) OCD 4 . Women 's participation require negative result betahuman chorionic gonadotropin pregnancy test stable use medically accept form contraception . 5 . Signed informed consent entry study . 1 . Unstable medical illness clinically significant abnormality laboratory test physical examination screen visit 2 . Current pregnancy lactation , inadequate contraception woman childbearing potential 3 . A need medication dronabinol possible psychotropic effect 4 . History hypersensitivity cannabinoid sesame oil 5 . Lifetime history bipolar disorder type I II , dementia , schizophrenia determine Structured Clinical Interview DSMIV 6 . Current ( past 12months ) DSMIV substance abuse dependence 7 . Positive urine drug screen screen 8 . Initiation cognitive behavior therapy within 3 month prior study baseline 9 . Baseline score ≥ 17 Hamilton Depression Rating Scale ( 17item HDRS 10 . Suicidality base clinical interview 11 . History head injury neurological disorder ( seizure )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Skin Picking</keyword>
	<keyword>OCD</keyword>
	<keyword>Trichotillomania</keyword>
	<keyword>Pathological Skin Picking</keyword>
</DOC>